Lili Brillstein on Mandatory, Voluntary Payment Models
May 29th 2020There will never be all mandatory payment models or all value-based models, but we can craft a value-based model around just about anything as long as everybody agrees on what the criteria is, said Lili Brillstein, CEO of Brillstein Collaborative Consulting, and former Director for Episodes of Care at Horizon Blue Cross Blue Shield of New Jersey.
Watch
Lili Brillstein Outlines Challenges of Incorporating Value-Based Care in Oncology
May 18th 2020New technologies and quick drug approvals contribute to the challenges of incorporating value-based care in oncology, said Lili Brillstein, CEO of Brillstein Collaborative Consulting, and former Director for Episodes of Care at Horizon Blue Cross Blue Shield of New Jersey.
Watch
Kelly Filchner Highlights Obstacles, Benefits of Transitioning Patients From Cancer Care to PCPs
May 7th 2020Raising awareness on the involvement of primary care providers can assist cancer survivors in transitioning from oncology care, said Kelly Filchner, MSN, director at Fox Chase Cancer Center Partners.
Watch
This Week in Managed Care: May 1, 2020
May 1st 2020The Supreme Court says insurers are owed $12 billion under the Affordable Care Act; a study finds those with cancer are at higher risk from coronavirus disease 2019 (COVID-19); a survey shows millions would avoid seeking care for COVID-19 due to cost.
Watch
Kelly Filchner Notes Barriers Preventing Integration of Primary Care Providers Into Oncology Care
April 30th 2020Innovations to promote communication between primary care providers, oncologists are vital to delineate distinct roles in oncology patient management, said Kelly Filchner, MSN, director at Fox Chase Cancer Center Partners.
Watch
PBMs and Community Oncology: "We Just Can't Let Them Get Away With What They're Doing"
April 25th 2020Despite the immediate distraction from coronavirus disease 2019 (COVID-19), panelists at the 2020 Virtual Community Oncology Conference said community oncologists must keep pressure on pharmacy benefit managers (PBMs) as the 2020 campaign heats up—lest they lose the momentum to rein PBM practices within the umbrella of drug pricing reform.
Read More
COA Consensus: Telemedicine Is Here to Stay, but Practice Transformation Could Stall
April 25th 2020The bright spot of telemedicine's success during the coronavirus disease 2019 pandemic cannot overshadow the stresses on patients and practices, which will both have ongoing challenges when the pandemic ends, said panelists during a legislative update on day 2 of the 2020 Virtual Community Oncology Conference, convened by the Community Oncology Alliance.
Read More
This Week in Managed Care: April 24, 2020
April 24th 2020This week, the top managed care news included HHS' plans to allocate the remaining $70 billion in COVID-19 funding to providers; an analysis finding aggressive social distancing measures economically justified; highlights from this week's virtual Community Oncology Conference.
Watch
Kelly Filchner on Importance of PCPs in Improving Coordination of Care for Cancer Survivors
April 23rd 2020Many patients when they start their cancer therapy get so ingrained in the cancer world that their oncologist just becomes their main point of contact, but we have to do a better job at letting the patients know that the PCP still is an integral part of their care, said Kelly Filchner, MSN, director at Fox Chase Cancer Center Partners.
Watch
Dr Dinesh Kapur on Value of Community Oncology, Developing AI Tools for Patient Care
April 22nd 2020The American Journal of Managed Care® (AJMC®) recently spoke with Dinesh Kapur, MD, of Eastern Connecticut Hematology and Oncology, also known as ECHO, an advanced community oncology conference. Kapur spoke about how the value of community oncology, clinicial trials, and how staff are spending remote work days developing artificial intelligence (AI) tools for predictive patient analytics to improve care.
Read More
COVID-19 Upends Drug Purchasing Patterns, and More Disruption Likely, IQVIA Expert Says
April 20th 2020Douglas M. Long, MBA, vice president of industry relations for IQVIA, surveyed the effects of COVID-19 as he kicked off AMCP eLearning Days, a webinar series held in place of the annual meeting of the Academy of Managed Care Pharmacy (AMCP).
Read More
Kathy Oubre: Witnessing Growing Cancer Survivorship Is a Privilege
April 20th 2020In this preview interview for this year’s virtual 2020 Community Oncology Conference, The American Journal of Managed Care® speaks with Kathy Oubre, MS, chief operating officer of Pontchartrain Cancer Center in Louisiana, on why it is her privilege to work with patients who have cancer, as well as her thoughts on telehealth after the pandemic and why being in a hurricane-prone area necessitates healthcare that is flexible.
Read More
Dr Lalan Wilfong: Groundbreaking Research to Be Presented at COA's 2020 Virtual Conference
April 18th 2020Individuals should register for Community Oncology Alliance's virtual meeting to hear "amazing" speakers present groundbreaking research, said Lalan Wilfong, MD, medical oncologist and vice president of value-based care and quality programs at Texas Oncology.
Watch
Dr Michael Diaz Outlines Important Lessons Learned From the OCM
April 15th 2020Networking with other practices, sharing ideas, and getting physicians involved in the process can aid community practices moving to alternative payment models (APMs), said Michael Diaz, MD, president of Community Oncology Alliance.
Watch
In Florida, Serving the Senior Population in Oncology Means Working Together
April 11th 2020“Quest for Value: Advancing Oncology Value-based Care,” this year’s first installment in the Institute for Value-Based Medicine (IVBM) from The American Journal of Managed Care®, zeroed in seniors, a population that’s growing not just in Florida but across the United States. Older Americans are more likely to develop cancer, but thanks to better detection and treatment, they are more likely to survive cancer, too.
Read More
What We're Reading: Oncology Treatment Delays; 3M, Trump Reach Agreement; HHS Surveys Hospitals
April 7th 2020Patients with cancer are reporting that they have faced treatment delays due to the novel coronavirus disease 2019 (COVID-19); the Trump administration reached an agreement with 3M Co. to produce nearly 167 million face masks in the next 3 months; US hospitals cite lack of supplies, testing coordination as major obstacles during the pandemic, according to an HHS survey.
Read More
Racial Bias May Impact Minority Participation in Cancer Trials
March 11th 2020Racial and ethnic biases held by research and clinical professionals could contribute to low minority participation in oncology clinical trials, according to a study recently published in Cancer, a journal from the American Cancer Society.
Read More
Dr Randall Oyer on Bridging the Gap Between Clinical Trial, Patient Needs in Community Oncology
March 10th 2020We think that the ACCC is uniquely positioned to bridge the gap between the needs in clinical trials and the patients who are in the community. Most clinical oncology is delivered in the community. That's where the patients are, that's where the need is, said Randall Oyer, MD, medical director of the Oncology Program at Penn Medicine Lancaster General Health and president of ACCC.
Watch
Dr Lucio Gordan Discusses Cost Differentials, Survivorship Care in Oncology
March 10th 2020There has been significant improvement in payers' understanding of site of care issues, but steps still need to be taken to address these issues, said Lucio Gordan, MD, president and managing physician at Florida Cancer Specialists.
Watch
Rebecca Kirch Highlights Challenges, Solutions to Overcoming Obstacles in Cancer Care Delivery
March 9th 2020Ensuring that all frontline clinicians are equipped, confident, and engaged in executing skilled communication, which is at the core of palliative care, will make a significant difference for how value-based care unfolds, how payment reform happens, and how the lived experience plays out for patients and families to be a better one, said Rebecca Kirch, JD, executive vice president, Health Care, Quality and Value, National Patient Advocate Foundation.
Watch